The clinical and molecular cardiometabolic fingerprint of an exploratory psoriatic arthritis cohort is associated with the disease activity and differentially modulated by methotrexate and apremilast-Reference-Cited by-同舟云学术

The clinical and molecular cardiometabolic fingerprint of an exploratory psoriatic arthritis cohort is associated with the disease activity and differentially modulated by methotrexate and apremilast

Published:2022-03-02 Issue:5 Volume:291 Page:676-693
ISSN:0954-6820
Container-title:Journal of Internal Medicine
language:en
Short-container-title:J Intern Med

Author:

Arias de la Rosa Ivan¹,López‐Montilla Maria Dolores¹,Román‐Rodríguez Cristobal¹,Pérez‐Sánchez Carlos¹,Gómez‐García Ignacio¹,López‐Medina Clementina¹,Ladehesa‐Pineda Maria Lourdes¹,Ábalos‐Aguilera Maria del Carmen¹,Ruiz Desiree¹,Patiño‐Trives Alejandra Maria¹,Luque‐Tévar Maria¹,Añón‐Oñate Isabel²,Pérez‐Galán Maria Jose²,Guzmán‐Ruiz Rocio¹³,Malagón Maria M.¹³,López‐Pedrera Chary¹^ORCID,Escudero‐Contreras Alejandro¹,Collantes‐Estévez Eduardo¹,Barbarroja Nuria¹^ORCID

Affiliation:

1. Maimonides Institute for Research in Biomedicine of Cordoba (IMIBIC)/Reina Sofia Hospital University of Cordoba Cordoba Spain

2. Rheumatology Department University Hospital of Jaen Jaen Spain

3. CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN) Instituto de Salud Carlos III Madrid Spain

Funder

Instituto de Salud Carlos III

Publisher

Wiley

Subject

Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/joim.13447